Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Gene Therapies in Ophthalmology Market Competitive Landscape Report 2026: Comprehensive Insights About 55+ Companies and 125+ Drugs by Product Type, Stage, Route of Administration, and Molecule Type

globenewswire.com
RGNX Regenxbio is listed as a company with a late-stage (Phase III) pipeline product, RGX-314, in the gene therapies for ophthalmology market. The article does not offer specific sentiment regarding the company's outlook.

Gene Therapies in Ophthalmology Market Competitive Landscape Report 2026: Comprehensive Insights About 55+ Companies and 125+ Drugs by Product Type, Stage, Route of Administration, and Molecule Type Dublin, April 09, 2026 (GLOBE NEWSWIRE) -- The "Gene Therapies in Ophthalmology - Competitive Landscape, 2026" report has been added to ResearchAndMarkets.com's offering.

This "Gene Therapies In Ophthalmology- Competitive landscape, 2026," report provides comprehensive insights about 55+ companies and 125+ drugs in Gene Therapies In Ophthalmology Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Key Questions

Key Players

Key Products

Key Topics Covered:

Introduction

Executive Summary

Gene Therapies in Ophthalmology: Overview

Gene Therapies in Ophthalmology-Analytical Perspective: In-depth Commercial Assessment

Competitive Landscape

Therapeutic Assessment

Gene Therapies in Ophthalmology: Company and Product Profiles (Marketed Therapies)

Spark Therapeutics

LUXTURNA

Gene Therapies in Ophthalmology: Company and Product Profiles (Pipeline Therapies)

Late Stage Products (Phase III)

Regenxbio

RGX-314

Mid Stage Products (Phase II/III)

Beacon Therapeutics

AGTC-501

Early Stage Products (Phase I/II)

Exegenesis Bio

EXG102-031

Preclinical and Discovery Stage Products

Company Name

Product Name

Inactive Products

Gene Therapies in Ophthalmology- Unmet needs

Gene Therapies in Ophthalmology- Market drivers and barriers

Appendix

For more information about this report visit https://www.researchandmarkets.com/r/nqk8bw

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.